Cannabis withdrawal peaked at day 4 and THC lingered in blood for over two weeks

Cannabis withdrawal symptoms peaked at day 4 of abstinence and declined by day 16, while nearly a third of patients still had detectable THC in their blood after 16 days of monitored abstinence.

Bonnet, U et al.·Drug and alcohol dependence·2014·Moderate EvidenceProspective Cohort
RTHC-00774Prospective CohortModerate Evidence2014RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Prospective Cohort
Evidence
Moderate Evidence
Sample
N=39

What This Study Found

Thirty-nine chronic cannabis-dependent patients were monitored during inpatient detoxification. Withdrawal symptoms peaked on day 4, with an average severity score of 10.4 out of 39 points, and declined to 2.9 points by day 16. The most dominant symptoms were craving, restlessness, nervousness, and sleeplessness. Clinical severity peaked at 5 out of 7 on a global impression scale ("markedly ill").

Women experienced significantly stronger withdrawal than men. On admission, THC and metabolite levels negatively correlated with withdrawal severity (higher levels meant less withdrawal, consistent with the pharmacological model). After admission, no correlation existed between blood levels and symptom severity.

Remarkably, 28.2% of patients still had THC blood levels above 1 ng/mL after 16 days of confirmed abstinence (range: 1.3 to 6.4 ng/mL), reflecting THC's storage in body fat and slow release.

Key Numbers

39 patients. Withdrawal peaked day 4 (10.4/39 points), declined to 2.9/39 by day 16. CGI-S peaked at 5/7. 28.2% still had THC above 1 ng/mL at day 16. Women had significantly stronger withdrawal than men.

How They Did This

Prospective observational study of 39 treatment-seeking cannabis dependents (ICD-10) in inpatient detoxification. Assessments at admission and abstinence days 2, 4, 8, and 16 using the Marijuana Withdrawal Checklist (MWC) and Clinical Global Impression-Severity scale. Serum THC, THC-OH, and THC-COOH were measured simultaneously.

Why This Research Matters

This study provided a detailed clinical timeline of cannabis withdrawal under controlled conditions. The finding that THC persists in blood for over two weeks has implications for drug testing, driving assessments, and understanding why some withdrawal symptoms may be prolonged.

The Bigger Picture

The disconnect between blood THC levels and withdrawal severity after the first day challenges simple pharmacological models of withdrawal. The slow clearance of THC from blood means that standard drug tests can remain positive for weeks after genuine abstinence, which has legal and employment implications.

What This Study Doesn't Tell Us

Relatively small sample of 39 patients. All were treatment-seeking, which may select for more severe dependence. Some patients received medications for withdrawal symptoms, though this did not affect the THC-withdrawal correlation. The study did not assess body composition, which affects THC storage and release.

Questions This Raises

  • ?Why do women experience stronger cannabis withdrawal?
  • ?Does residual THC in blood contribute to prolonged or rebound symptoms?
  • ?Would body fat percentage predict THC clearance rate and withdrawal timeline?

Trust & Context

Key Stat:
28% still had detectable blood THC after 16 days of confirmed abstinence
Evidence Grade:
Prospective inpatient study with objective blood measurements and validated withdrawal scales, though limited by small sample size.
Study Age:
Published in 2014.
Original Title:
Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum.
Published In:
Drug and alcohol dependence, 143, 189-97 (2014)
Database ID:
RTHC-00774

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-ControlFollows or compares groups over time
This study
Cross-Sectional / Observational
Case Report / Animal Study

Enrolls participants and follows them forward in time.

What do these levels mean? →

Frequently Asked Questions

When does cannabis withdrawal peak?

In this study, symptoms peaked at day 4 of abstinence, with craving, restlessness, nervousness, and sleeplessness as the dominant complaints. Symptoms declined substantially by day 16.

How long does THC stay in your blood after quitting?

After 16 days of confirmed inpatient abstinence, 28.2% of patients still had THC above 1 ng/mL in their blood (up to 6.4 ng/mL), reflecting THC stored in body fat being slowly released.

Read More on RethinkTHC

Cite This Study

RTHC-00774·https://rethinkthc.com/research/RTHC-00774

APA

Bonnet, U; Specka, M; Stratmann, U; Ochwadt, R; Scherbaum, N. (2014). Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum.. Drug and alcohol dependence, 143, 189-97. https://doi.org/10.1016/j.drugalcdep.2014.07.027

MLA

Bonnet, U, et al. "Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum.." Drug and alcohol dependence, 2014. https://doi.org/10.1016/j.drugalcdep.2014.07.027

RethinkTHC

RethinkTHC Research Database. "Abstinence phenomena of chronic cannabis-addicts prospective..." RTHC-00774. Retrieved from https://rethinkthc.com/research/bonnet-2014-abstinence-phenomena-of-chronic

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.